Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-363041f1384c6cb2: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-795f50a2377ffc4d: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-0b2d170a584012f8: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-4d6c1c8f450f3cda: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-79b65340f5ddd334: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-9efa55afc5b33338: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-8eb619106e0a0ad7: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-5c5df87d0f07067d: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-c6df52dea30140df: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-907e2eb9032d7b1f: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-363041f1384c6cb2
- pantheon_debate:pd-795f50a2377ffc4d
- pantheon_debate:pd-0b2d170a584012f8
- pantheon_debate:pd-4d6c1c8f450f3cda
- pantheon_debate:pd-79b65340f5ddd334
- pantheon_debate:pd-9efa55afc5b33338
- pantheon_debate:pd-8eb619106e0a0ad7
- pantheon_debate:pd-5c5df87d0f07067d
- pantheon_debate:pd-c6df52dea30140df
- pantheon_debate:pd-907e2eb9032d7b1f
Context
{"topic":"general","source_refs":["pantheon_debate:pd-363041f1384c6cb2","pantheon_debate:pd-795f50a2377ffc4d","pantheon_debate:pd-0b2d170a584012f8","pantheon_debate:pd-4d6c1c8f450f3cda","pantheon_debate:pd-79b65340f5ddd334","pantheon_debate:pd-9efa55afc5b33338","pantheon_debate:pd-8eb619106e0a0ad7","pantheon_debate:pd-5c5df87d0f07067d","pantheon_debate:pd-c6df52dea30140df","pantheon_debate:pd-907e2eb9032d7b1f"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10